Dec 31, 2021

Entrada Therapeutics Q4 2021 Earnings Report

EPS
-$0.89
Previous year: -$53.9
-98.3%
Cash and Equivalents
$291M
Previous year: $39M
+645.5%
Free Cash Flow
-$21.9M
Previous year: -$8.07M
+171.0%
Total Assets
$306M
Previous year: $43.5M
+602.6%

Entrada Therapeutics

Entrada Therapeutics